Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaya Sugiyama

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Global Health & Medicine|May 2, 2023
Tools and factors predictive of the severity of COVID-19Masaya Sugiyama
Hepatology (Baltimore, Md.)|July 14, 2016
Dual blockade of hepatitis C virus entry at a gatekeeper of hepatocytes: Not only a preventive, but also therapeutic target of claudin 1Masaya Sugiyama, Tatsuya Kanto
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 22, 2011
[Genome-wide association study and clinical application]Masaya Sugiyama, Masashi Mizokami
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 22, 2011
[Hepatitis B virus genotype and the mutation related to clinical outcome]Masaya Sugiyama, Masashi Mizokami
Uirusu|October 7, 2011
[Genome-wide association study on and the clinical application to chronic hepatitis C]Masaya Sugiyama, Masashi Mizokami
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[Hepatitis B virus genotype and the mutation related to clinical outcome]Masaya Sugiyama, Masashi Mizokami
Uirusu|November 30, 2012
[Present state and the future direction of HBV vaccine]Masashi Mizokami, Masaya Sugiyama
Uirusu|September 21, 2010
[Direct cytopathic effects of particular hepatitis B virus genotypes in immunosuppressive condition]Yasuhito Tanaka, Masaya Sugiyama, Masashi Mizokami
Journal of Pharmacological Sciences|February 26, 2011
Novel findings for the development of drug therapy for various liver diseases: Genetic variation in IL-28B is associated with response to the therapy for chronic hepatitis CMasaya Sugiyama, Yasuhito Tanaka, Makoto Nakanishi, et al.
Journal of Medical Virology|July 23, 2024
Incidences of new hepatitis B infection and anti-hepatitis B core-negative occult hepatitis B infection among Japanese blood donors in relation to anti-hepatitis B surface antigen levelsMasahiro Satake, Masaya Sugiyama, Masashi Mizokami, et al.
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Global Health & Medicine|May 2, 2023
Tools and factors predictive of the severity of COVID-19Masaya Sugiyama
Hepatology (Baltimore, Md.)|July 14, 2016
Dual blockade of hepatitis C virus entry at a gatekeeper of hepatocytes: Not only a preventive, but also therapeutic target of claudin 1Masaya Sugiyama, Tatsuya Kanto
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 22, 2011
[Genome-wide association study and clinical application]Masaya Sugiyama, Masashi Mizokami
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 22, 2011
[Hepatitis B virus genotype and the mutation related to clinical outcome]Masaya Sugiyama, Masashi Mizokami
Uirusu|October 7, 2011
[Genome-wide association study on and the clinical application to chronic hepatitis C]Masaya Sugiyama, Masashi Mizokami
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[Hepatitis B virus genotype and the mutation related to clinical outcome]Masaya Sugiyama, Masashi Mizokami
Uirusu|November 30, 2012
[Present state and the future direction of HBV vaccine]Masashi Mizokami, Masaya Sugiyama
Uirusu|September 21, 2010
[Direct cytopathic effects of particular hepatitis B virus genotypes in immunosuppressive condition]Yasuhito Tanaka, Masaya Sugiyama, Masashi Mizokami
Journal of Pharmacological Sciences|February 26, 2011
Novel findings for the development of drug therapy for various liver diseases: Genetic variation in IL-28B is associated with response to the therapy for chronic hepatitis CMasaya Sugiyama, Yasuhito Tanaka, Makoto Nakanishi, et al.
Journal of Medical Virology|July 23, 2024
Incidences of new hepatitis B infection and anti-hepatitis B core-negative occult hepatitis B infection among Japanese blood donors in relation to anti-hepatitis B surface antigen levelsMasahiro Satake, Masaya Sugiyama, Masashi Mizokami, et al.
Pageof 22